2020 (v1)
Publication
No description
Uploaded on: April 14, 2023
D
A
Last name: DAMASSI
First name: Alessandra
No description
No description
No description
No description
No description
: Introduction: The Meet-URO 18 study is a multicentric study of patients with metastatic renal cell carcinoma receiving nivolumab in the second-line and beyond, categorized as responders (progression-free survival ≥ 12 months) and non-responders (progression-free survival < 3 months). Areas covered: The current study includes extensive...